© 2020 MJH Life Sciences and OncLive. All rights reserved.
June 19, 2020
Michael J. Morris, MD, discusses factors to consider when deciding among PET tracers in prostate cancer.
June 15, 2020
Michael J. Morris, MD, discusses the promising future of prostate-specific membrane antigen–targeted PET imaging in prostate cancer.
June 05, 2020
Michael J. Morris, MD, discusses the impact of prostate-specific membrane antigen-targeted imaging with 18F-DCFPyL-PET/CT on the clinical management of patients with prostate cancer.
December 17, 2018
Michael J. Morris, MD, medical oncologist, clinical director, Genitourinary Medical Oncology Service, Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses biomarkers in prostate cancer.